APP and Alzheimer disease: While these initial experiments were key for establishing the technique and its feasibility, there are limitations with respect to the AppNL-G-F model whereby the Arctic mutation of APP alters the chemical properties of Aβ leading to an increased aggregation propensity not seen in sporadic AD.